RIVAROXABAN Mepha vascular cpr pell 2.5 mg 196 pce
7680684400025
CH-68440
B01AF01
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Rivaroxaban-Mepha vascular 2.5 mg Filmtabletten
Filmtabletten
196
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rivaroxabanum
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
lactosum monohydricum
|
184.7 MG | Substance | HBESI |
|
hypromellosum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 118.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2024
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68440
- Drug name
- Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten
- Galenic form
- FILM
- ATC Code
- B01AF01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 06/04/2022
- Authorization expiration date
- 31/12/9999
- IT number
- 06.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RIVAROXABAN Mepha vascular cpr pell 2.5 mg 196 pce
- Description (DE)
- RIVAROXABAN Mepha vascular Filmtabl 2.5 mg 196 Stk
- Market launch
- 06/04/2022
- Narcotic (BTM)
- No